Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ezetimibe.php on line 2
Ezetimibe
LE WE PMID CA
Ezetimibe866Ezetimib

Avasimibe

Cholesterol

Colesevelam

ERS UFR (Pharmacology)

Ezetimibe

Fibrate

Implitapide

Insulin (resistance)

Lipoprotein (Dyslipoproteinemia Hyperlipoproteinemia)

Niacin

NPC1L1 Niemann Pick C1 Like1

Statin

Torcetrapib

Transporter (Cholesterol)

2008  
1
Given the ENHANCE trial results, ezetimibe is still unproven.
[18646585] Cleve Clin J Med 75(7): 497-8, 502, 505-6 (2008)
2003  
2
Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.
[14647533] Cardiovasc Drug Rev 21(4): 293-312 (2003)
2008  
3
Combination therapy in cholesterol reduction: focus on ezetimibe and statins.
[18561502] Vasc Health Risk Manag 4(2): 267-78 (2008)
2008  
4
Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
[18485273] Health Technol Assess 12(21): iii, xi-xiii, 1-212 (2008)
2008  
5
Ezetimibe blocks internalization of the NPC1L1/cholesterol complex.
[18522826] Cell Metab 7(6): 469-71 (2008)
2008  
6
Ezetimibe, a selective inhibitor of the transport of cholesterol.
[18591835] Intern Med 47(13): 1165-70 (2008)
2005  
7
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
[15887425] Mayo Clin Proc 80(5): 587-95 (2005)
2008  
8
Use of ezetimibe in the United States and Canada.
[18375999] N Engl J Med 358(17): 1819-28 (2008)
2006  
9
2010  
10
NPC1L1 and cholesterol transport.
[20307540] FEBS Lett 584(13): 2740-7 (2010)
2010  
11
Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
[21060168] Saudi J Kidney Dis Transpl 21(6): 1021-9 (2010)
2011  
12
Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.
[21438815] Expert Rev Cardiovasc Ther 9(3): 355-66 (2011)
2008  
13
2009  
14
Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance.
[19654286] Am J Physiol Endocrinol Metab 297(5): E1030-8 (2009)
2002  
15
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.
[12236852] Br J Clin Pharmacol 54(3): 309-19 (2002)
2007  
16
Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
[17587760] J Atheroscler Thromb 14(3): 99-108 (2007)
2011  
17
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia.
[22020943] Neth Heart J 19(2): 61-7 (2011)
2009  
18
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.
[19821987] Lipids Health Dis 8(-): 41 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ezetimibe.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Ezetimibe.php on line 92